Status Epilepticus: Immediate Management and Approach to Refractory Cases

 

Status Epilepticus: Immediate Management and Approach to Refractory Cases - A Critical Care Perspective

Dr Neeraj Manikath , claude.ai

Abstract

Status epilepticus (SE) represents a neurological emergency requiring immediate intervention to prevent significant morbidity and mortality. This review provides evidence-based guidelines for the acute management of generalized convulsive status epilepticus, refractory status epilepticus (RSE), and super-refractory status epilepticus (SRSE), with emphasis on practical clinical decision-making in the critical care setting. We highlight critical time-dependent interventions, common pitfalls in management, and emerging therapeutic approaches for treatment-resistant cases.

Keywords: Status epilepticus, refractory status epilepticus, super-refractory status epilepticus, critical care, emergency management

Introduction

Status epilepticus is defined as continuous seizure activity lasting more than 5 minutes, or two or more discrete seizures without full recovery of consciousness between episodes.¹ The operational definition has evolved from the traditional 30-minute threshold to reflect the urgency of early intervention. Generalized convulsive status epilepticus (GCSE) affects approximately 20-40 per 100,000 people annually, with mortality rates ranging from 15-25% depending on etiology and treatment delay.²

The pathophysiology involves progressive pharmacoresistance due to internalization of synaptic GABA receptors and upregulation of NMDA receptors, making early aggressive treatment crucial. Each minute of delay in achieving seizure control increases the risk of neuronal injury and treatment resistance.³

PEARL #1: The "5-Minute Rule"

Modern SE definition emphasizes 5 minutes, not 30. Brain imaging shows neuronal damage beginning at 5 minutes of continuous seizure activity. Don't wait - treat aggressively from the start.

Immediate Management of Status Epilepticus

Phase I: Initial Stabilization (0-5 minutes)

Primary Assessment:

• Ensure airway patency and adequate ventilation
• Establish IV access (preferably two large-bore IVs)
• Monitor vital signs and neurological status
• Obtain bedside glucose and electrolytes
• Consider thiamine 100mg IV if alcohol use suspected

First-Line Treatment: Benzodiazepines remain the gold standard for initial SE management:

1. Lorazepam 0.1 mg/kg IV (maximum 4mg per dose)

   • May repeat once after 5-10 minutes
   • Preferred due to longer half-life and less redistribution

2. Alternative options:

   • Diazepam 0.2 mg/kg IV (maximum 10mg)
   • Midazolam 10mg IM if IV access difficult

HACK #1: The "Double IV" Strategy

Always establish two IV lines immediately - one for antiepileptic drugs (AEDs) and one for other medications. AEDs can cause significant venous irritation and line failure.

Phase II: Second-Line Therapy (5-20 minutes)

If seizures persist after adequate benzodiazepine administration, immediately proceed to second-line agents:

Evidence-Based Options:

1. Fosphenytoin 20 PE/kg IV (Phenytoin Equivalents)

   • Loading dose over 10-20 minutes
   • Maximum infusion rate: 150 PE/min
   • Monitor for hypotension and cardiac arrhythmias

2. Valproate 40 mg/kg IV

   • Loading dose over 10 minutes
   • Avoid in hepatic dysfunction or mitochondrial disorders
   • Consider in idiopathic generalized epilepsy

3. Levetiracetam 60 mg/kg IV

   • Loading dose over 15 minutes
   • Safer profile but possibly less effective than phenytoin⁴
   • Preferred in elderly or those with cardiac comorbidities

PEARL #2: The "RAMPART Protocol"

Recent studies suggest equivalent efficacy between the three second-line agents. Choose based on patient factors: fosphenytoin for most cases, valproate for genetic epilepsy, levetiracetam for elderly/cardiac patients.

Phase III: Third-Line Therapy - Early Refractory Status (20-60 minutes)

Failure to respond to adequate doses of first and second-line therapy defines early refractory status epilepticus. Immediate ICU admission and continuous EEG monitoring are mandatory.

Anesthetic Options:

1. Midazolam

   • Loading: 0.2 mg/kg IV bolus
   • Maintenance: 0.05-0.5 mg/kg/hr
   • Titrate to seizure suppression or burst-suppression

2. Propofol

   • Loading: 1-2 mg/kg IV bolus
   • Maintenance: 1-10 mg/kg/hr
   • Risk of propofol-related infusion syndrome >48 hours

3. Pentobarbital

   • Loading: 5-10 mg/kg IV
   • Maintenance: 0.5-3 mg/kg/hr
   • Most effective but highest complication rate

OYSTER #1: The "Propofol Trap"

Propofol is often chosen for its familiarity, but beware: it has the shortest duration of action. Seizures often return immediately upon weaning. Consider longer-acting agents for sustained control.

Refractory Status Epilepticus (RSE)

RSE is defined as SE continuing after treatment with a benzodiazepine and one appropriately dosed second-line AED. This affects approximately 30-40% of SE patients and carries significantly higher morbidity and mortality.⁵

Advanced Management Strategies:

Continuous EEG Monitoring:

• Essential for RSE management
• Target: seizure freedom or burst-suppression pattern
• Monitor for non-convulsive seizures during treatment

Anesthetic Goals:

• Achieve seizure suppression for 12-24 hours
• Consider burst-suppression pattern for severely refractory cases
• Balance seizure control with hemodynamic stability

HACK #2: The "Titration Triangle"

Use a three-agent approach: midazolam for rapid onset, pentobarbital for deep suppression, and a long-acting AED (like lacosamide) for bridge therapy. This provides layered protection during weaning.

Additional AED Options:

• Lacosamide 400-800mg daily
• Topiramate 300-1600mg daily (via NG tube)
• Pregabalin 150-600mg daily

Super-Refractory Status Epilepticus (SRSE)

SRSE is defined as SE continuing for ≥24 hours after initiation of anesthetic therapy, including cases that recur during weaning attempts. This represents the most challenging form of SE with mortality approaching 50%.⁶

Experimental and Rescue Therapies:

Immunomodulatory Approaches:

• High-dose steroids (methylprednisolone 1g daily × 3-5 days)
• IVIG (0.4 g/kg daily × 5 days)
• Plasmapheresis for suspected autoimmune etiology

Emerging Therapies:

• Ketamine (1-7 mg/kg/hr continuous infusion)
• Inhaled anesthetics (isoflurane, sevoflurane)
• Hypothermia (32-34°C for 24-72 hours)
• Vagus nerve stimulation
• Electroconvulsive therapy⁷

PEARL #3: The "Autoimmune Window"

Consider autoimmune encephalitis in SRSE, especially in young adults with new-onset seizures. Early immunotherapy can be life-saving. Don't wait for antibody results - treat empirically if clinical suspicion is high.

Ketogenic Diet Therapy:

• Rapid implementation possible via NG tube
• Target ketosis within 2-4 days
• Effective in 50-70% of pediatric SRSE cases⁸
• Limited adult data but increasingly used

HACK #3: The "Metabolic Reset"

For SRSE, consider the ketogenic diet as early as day 3-5. Use a 4:1 ratio (fat:carbohydrate+protein) and monitor ketones q6h. It's not just for kids - adults can benefit too.

Monitoring and Complications

Critical Monitoring Parameters:

• Continuous EEG (minimum 24-48 hours)
• Hemodynamic stability
• Respiratory function
• Electrolyte balance (especially sodium, phosphorus)
• Hepatic and renal function
• Signs of rhabdomyolysis

Common Complications:

• Hypotension (50-70% of cases)
• Respiratory depression requiring intubation
• Aspiration pneumonia
• Cardiac arrhythmias
• Acute kidney injury
• Rhabdomyolysis

OYSTER #2: The "Silent Seizure"

Up to 48% of patients have non-convulsive seizures after apparent clinical control. Always continue EEG monitoring for 24-48 hours after clinical seizure cessation. The brain may still be seizing silently.

Prognosis and Long-term Outcomes

Outcome depends primarily on:

• Etiology (acute symptomatic vs. remote symptomatic)
• Duration before treatment initiation
• Patient age and comorbidities
• Development of complications

Favorable Prognostic Indicators:

• Shorter duration before treatment
• Younger age
• Absence of structural brain lesions
• Rapid response to initial therapy

Poor Prognostic Indicators:

• SRSE lasting >7 days
• Need for multiple anesthetic agents
• Development of medical complications
• Elderly age with multiple comorbidities

PEARL #4: The "Golden Hour Extended"

While the first hour is critical, don't give up hope. Some patients with SRSE lasting weeks can still have good outcomes, especially if there's no underlying structural pathology. Persistence in care can be rewarded.

Special Populations

Elderly Patients:

• Higher mortality risk (up to 50%)
• More sensitive to medication side effects
• Consider underlying metabolic causes
• Prefer levetiracetam or lacosamide as second-line agents

Pregnancy:

• Fetal considerations for drug selection
• Avoid valproate (teratogenic)
• Phenytoin and levetiracetam generally safe
• Multidisciplinary approach with obstetrics

Post-cardiac Arrest:

• High association with hypoxic-ischemic encephalopathy
• Poor prognosis indicator
• Consider therapeutic hypothermia
• Myoclonus vs. true seizures distinction crucial

HACK #4: The "Pregnancy Protocol"

In pregnant patients with SE: Levetiracetam first, then phenytoin if needed. Avoid valproate at all costs. Remember - controlling maternal seizures is the priority for both mother and fetus.

Quality Improvement and Systems Approaches

Protocol Implementation:

• Standardized order sets
• Rapid response teams
• EEG technician availability
• Critical care neurology consultation

Common Pitfalls to Avoid:

• Inadequate benzodiazepine dosing
• Delayed second-line therapy
• Failure to recognize non-convulsive seizures
• Premature discontinuation of monitoring
• Under-recognition of autoimmune causes

OYSTER #3: The "Dose Trap"

Many physicians under-dose AEDs in SE. Use weight-based dosing religiously: lorazepam 0.1 mg/kg, fosphenytoin 20 PE/kg, valproate 40 mg/kg. Half-doses lead to treatment failure.

Future Directions

Emerging research focuses on:

• Novel AEDs with rapid onset profiles
• Precision medicine approaches based on genetic markers
• Advanced neuroimaging for prognosis
• Neuroprotective strategies
• Artificial intelligence for seizure prediction

Clinical Decision-Making Algorithm

Immediate Actions (0-5 minutes):

1. ABCs assessment
2. IV access × 2
3. Lorazepam 0.1 mg/kg IV
4. Bedside glucose, thiamine if indicated

Early Management (5-20 minutes):

1. If seizures persist → Second-line AED
2. Choose based on patient factors
3. Prepare for ICU admission

Refractory Management (20+ minutes):

1. ICU admission mandatory
2. Continuous EEG monitoring
3. Anesthetic therapy initiation
4. Consider underlying etiology workup

Super-Refractory Approach (>24 hours):

1. Experimental therapies
2. Immunomodulation consideration
3. Ketogenic diet
4. Family discussions regarding prognosis

PEARL #5: The "Team Sport"

SE management is never a solo effort. Involve critical care, neurology, pharmacy, EEG tech, and nursing from the start. Good communication saves lives and improves outcomes.

Conclusion

Status epilepticus remains a challenging neurological emergency requiring rapid, aggressive intervention. Success depends on early recognition, appropriate medication selection and dosing, and continuous monitoring for complications. While RSE and SRSE carry significant mortality risk, emerging therapies offer hope for previously treatment-resistant cases. A systematic, protocol-driven approach combined with individualized care based on patient factors and etiology provides the best chance for favorable outcomes.

The key to success lies not just in knowing what medications to give, but when to escalate therapy, how to monitor for complications, and when to consider experimental approaches. As our understanding of SE pathophysiology evolves, so too must our treatment strategies, always balancing aggressive intervention with patient safety and quality of life considerations.

---

References

1. Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515-1523.

2. Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care. 2014;20(3):476-483.

3. Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205-210.

4. Kapur J, Elm J, Chamberlain JM, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381(22):2103-2113.

5. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134(10):2802-2818.

6. Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62(11):1698-1702.

7. Ferlisi M, Hocker S, Trinka E, et al. Preliminary results of the global audit of treatment of refractory status epilepticus. Epilepsy Behav. 2015;49:318-324.

8. Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia. 2010;51(10):2033-2037.

Conflicts of Interest: None declared

Funding: None

The First Five Minutes of Cardiac Arrest in the Intensive Care Unit

 

The First Five Minutes of Cardiac Arrest in the Intensive Care Unit: Maximizing Outcomes Through Evidence-Based Immediate Management

Dr Neeraj Manikath , claude.ai

Abstract

Background: In-hospital cardiac arrest (IHCA) in the intensive care unit (ICU) represents a critical emergency where the initial response within the first five minutes significantly determines patient outcomes. Despite advanced monitoring and immediate availability of trained personnel, ICU cardiac arrest mortality remains substantial at 60-80%.

Objective: To provide evidence-based recommendations for optimizing the immediate management of cardiac arrest in the ICU setting during the crucial first five minutes, highlighting practical pearls, common pitfalls, and innovative approaches.

Methods: Comprehensive review of current literature, international guidelines, and expert consensus on ICU cardiac arrest management, with emphasis on interventions within the first 300 seconds.

Key Findings: The ICU environment offers unique advantages including continuous monitoring, immediate access to advanced airways, mechanical CPR devices, and extracorporeal support. However, specific challenges include complex patient populations, medication interactions, and decision-making regarding continuation versus limitation of care.

Conclusions: A systematic, time-sensitive approach to the first five minutes of ICU cardiac arrest, incorporating high-quality CPR, rapid rhythm analysis, immediate reversible cause identification, and judicious use of advanced ICU-specific interventions can significantly improve survival and neurological outcomes.

Keywords: Cardiac arrest, intensive care, cardiopulmonary resuscitation, critical care, emergency response

---

Introduction

Cardiac arrest in the intensive care unit presents a unique clinical scenario that differs significantly from ward-based or out-of-hospital cardiac arrest. While ICU patients benefit from continuous monitoring, immediate access to advanced life support equipment, and the presence of trained critical care personnel, they often have multiple comorbidities, are on complex medication regimens, and may have pre-existing organ dysfunction that complicates resuscitation efforts.

The first five minutes following recognition of cardiac arrest represent the most critical period for intervention. During this timeframe, the quality of chest compressions, speed of defibrillation, and identification of reversible causes can dramatically influence both survival to discharge and neurological outcomes. Recent data suggest that survival from ICU cardiac arrest ranges from 20-40%, with neurologically intact survival occurring in 15-30% of cases.

This review synthesizes current evidence and expert recommendations to optimize management during these crucial first 300 seconds, providing practical guidance for critical care practitioners.

---

The Critical Timeline: Second-by-Second Analysis

Seconds 0-30: Recognition and Activation

Immediate Actions:

• Confirm cardiac arrest: Check responsiveness and pulse (maximum 10 seconds)
• Call for help: Activate code blue team while beginning CPR
• Position patient: Ensure supine position on firm surface

Pearl: In mechanically ventilated patients, sudden loss of end-tidal CO2 (ETCO2) with concurrent arrhythmia is often the first indicator of cardiac arrest, preceding pulse check.

Oyster: Don't delay CPR to remove family members from bedside - assign a team member to provide support and explanation while resuscitation continues.

Seconds 30-60: High-Quality CPR Initiation

Immediate Actions:

• Begin chest compressions: 100-120/min, depth 2-2.4 inches (5-6 cm)
• Ensure adequate ventilation: If intubated, continue mechanical ventilation at 10 breaths/min
• Apply defibrillator pads: If not already connected to monitor

Hack: Use the bed's CPR mode immediately - this firms the surface and optimizes compression effectiveness. Many ICU beds have a "CPR button" that should be activated within the first 30 seconds.

Pearl: In ICU patients, avoid hyperventilation even more strictly than in other settings, as ICU patients often have pre-existing lung pathology that makes them more susceptible to ventilation-induced hemodynamic compromise.

Seconds 60-120: Rhythm Analysis and Defibrillation

Immediate Actions:

• Analyze rhythm: Minimize CPR interruptions (<10 seconds)
• Defibrillate if indicated: VF/pVT - deliver shock immediately
• Continue CPR: Resume compressions within 10 seconds of shock

Pearl: ICU patients often develop VF/pVT as initial rhythm (40-50% vs. 25% on wards) due to electrolyte abnormalities, drug effects, and underlying cardiac disease.

Hack: Pre-charge the defibrillator during CPR when VF/pVT is suspected based on monitor waveform - this can save 10-15 seconds.

Seconds 120-180: Medication Administration and Advanced Interventions

Immediate Actions:

• Establish vascular access: Use existing central lines when possible
• Administer epinephrine: 1 mg IV/IO every 3-5 minutes for non-shockable rhythms
• Consider advanced airway: If not already intubated

ICU-Specific Considerations:

• Existing vasoactive drips: Continue norepinephrine/vasopressin infusions during arrest
• Existing central access: Utilize for medication administration
• Mechanical ventilation: Adjust to 10 breaths/min, FiO2 1.0

Pearl: In ICU patients on vasoactive support, don't discontinue existing drips during arrest - they may provide beneficial effects during CPR.

Seconds 180-300: Reversible Causes and ICU-Specific Interventions

The ICU "6 H's and 6 T's" Plus:

Traditional Reversible Causes:

• Hypovolemia: Fluid bolus, blood products if indicated

• Hypoxia: Optimize ventilation, consider pneumothorax

• Hydrogen ions (acidosis): Rarely give bicarbonate in first 5 minutes

• Hyperkalemia/Hypokalemia: Check recent labs, give calcium if hyperkalemic

• Hypothermia: Rewarm if <32°C

• Hypoglycemia: Check glucose, give dextrose if indicated

• Thrombosis (coronary): Consider thrombolytics in appropriate patients

• Thrombosis (pulmonary): High suspicion in ICU patients

• Tamponade: POCUS evaluation, consider pericardiocentesis

• Tension pneumothorax: Needle decompression

• Toxins: Review medication list, consider specific antidotes

• Tablets/Trauma: Consider recent procedures, bleeding

ICU-Specific Additions:

• Mechanical ventilator malfunction: Switch to bag-mask ventilation
• Medication errors/interactions: Review recent medication administration
• Procedural complications: Recent lines, procedures, interventions

---

Advanced ICU-Specific Interventions

Mechanical CPR Devices

Indications for immediate deployment:

• Anticipated prolonged resuscitation
• Need for procedures during CPR (echocardiography, central access)
• Provider fatigue concerns
• Transport requirements

Pearl: Deploy mechanical CPR devices early (within 2-3 minutes) rather than waiting for provider fatigue - transition time is shorter when done earlier.

Point-of-Care Ultrasound (POCUS)

Integration into CPR cycle:

• Perform during pulse checks (minimize interruptions)
• Focus on: cardiac standstill vs. PEA, tamponade, pneumothorax, hypovolemia

Hack: Designate one person as "POCUS operator" who is ready with probe during each pulse check to minimize rhythm analysis delays.

Extracorporeal CPR (ECPR)

Consider early in select patients:

• Age <65 years with good neurological baseline
• Witnessed arrest with bystander CPR
• Initial shockable rhythm
• No significant comorbidities

Pearl: If ECPR is available, the decision to initiate should be made within the first 10-15 minutes of arrest, requiring consideration during the initial resuscitation phase.

---

Quality Metrics and Real-Time Optimization

Continuous Quality Assessment

Monitor in real-time:

• Compression depth and rate: Use CPR feedback devices
• ETCO2 levels: Target >20 mmHg during CPR
• Arterial pressure: If arterial line present, aim for diastolic >25 mmHg
• Compression fraction: Target >80%

Hack: Assign a "quality officer" whose sole responsibility is monitoring CPR metrics and providing real-time feedback.

Team Dynamics and Communication

Closed-Loop Communication:

• Clear role assignments within first minute
• Designated team leader (usually senior ICU physician)
• Time-keeper to announce intervals
• Medication recorder

Pearl: The ICU team has an advantage in knowing the patient's history - designate someone to provide a rapid 30-second background summary to responding team members.

---

Common Pitfalls and How to Avoid Them

Clinical Pitfalls

1. Delayed recognition in sedated patients

   • Solution: Continuous end-tidal CO2 monitoring
   • Watch for sudden ETCO2 drop with concurrent arrhythmia

2. Over-reliance on technology

   • Solution: Always confirm pulse absence manually
   • Don't trust monitor readings in isolation

3. Inadequate compression depth on ICU beds

   • Solution: Activate CPR mode immediately
   • Consider moving to floor if bed malfunction

4. Medication dosing errors in obese patients

   • Solution: Use actual body weight for epinephrine
   • Have weight-based dosing cards readily available

System Pitfalls

1. Unclear code team leadership

   • Solution: Pre-designated ICU physician as team leader
   • Clear role assignments posted in rooms

2. Equipment failures

   • Solution: Daily equipment checks
   • Backup defibrillator immediately available

3. Family communication delays

   • Solution: Assign team member to family support immediately
   • Don't delay care for family discussions

---

Special Populations in the ICU

Post-Cardiac Surgery Patients

Special Considerations:

• Emergency resternotomy equipment immediately available
• Higher likelihood of tamponade or bleeding
• Different medication considerations (anticoagulation status)

Pearl: In recent cardiac surgery patients (<7 days), have emergency resternotomy kit at bedside and consider early chest opening if arrest persists >5 minutes.

Transplant Recipients

Modified Approach:

• Consider rejection/infection as precipitating factors
• Immunosuppression affects response to medications
• Higher baseline risk factors

Patients on ECMO/Mechanical Support

Unique Considerations:

• Circuit evaluation as primary assessment
• May not require chest compressions if adequate flow
• Specialized team activation required

---

Evidence-Based Recommendations

Class I Recommendations (Strong Evidence)

1. High-quality CPR with minimal interruptions and adequate compression depth
2. Early defibrillation for VF/pVT within 3 minutes of recognition
3. Continuous ETCO2 monitoring during resuscitation
4. Systematic approach to reversible causes within first 5 minutes

Class IIa Recommendations (Moderate Evidence)

1. Mechanical CPR devices for anticipated prolonged resuscitation
2. POCUS integration into pulse checks for reversible cause identification
3. Continuation of vasoactive medications during arrest in ICU patients
4. Early ECPR consideration in appropriate candidates

Class IIb Recommendations (Limited Evidence)

1. Prophylactic antiarrhythmic administration in post-ROSC phase
2. Higher epinephrine dosing in patients on chronic vasoactive support
3. Extended resuscitation times in hypothermic patients

---

Innovative Approaches and Future Directions

Artificial Intelligence Integration

Emerging Applications:

• Real-time CPR quality feedback
• Predictive modeling for arrest risk
• Automated rhythm analysis and treatment recommendations

Personalized Resuscitation

Tailored Approaches:

• Genetic markers affecting drug metabolism
• Pre-existing condition-specific protocols
• Real-time biomarker-guided therapy

Enhanced Team Communication

Technology Solutions:

• Augmented reality for real-time guidance
• Voice-activated medication preparation
• Automated documentation systems

---

Practical Implementation Strategy

Pre-Event Preparation

Daily Readiness:

1. Equipment check (defibrillator, medications, airways)
2. Team role assignments and briefing
3. Patient-specific considerations review
4. Family meeting documentation review

Environmental Optimization:

1. Clear access to bedside from multiple angles
2. CPR-capable bed surface confirmed
3. Emergency medication kit location verified
4. Communication systems functional

Post-Event Analysis

Immediate Debriefing (within 24 hours):

• Timeline reconstruction
• Quality metrics review
• Team performance evaluation
• System issues identification

Long-term Quality Improvement:

• Monthly case review meetings
• Trending of key performance indicators
• Equipment and protocol updates
• Training needs assessment

---

Conclusions

The first five minutes of cardiac arrest in the ICU represent a critical window where evidence-based, systematic intervention can significantly impact patient outcomes. The unique ICU environment provides both advantages and challenges that must be leveraged and addressed respectively.

Key success factors include:

1. Immediate high-quality CPR with minimal delays
2. Rapid rhythm recognition and defibrillation when indicated
3. Systematic evaluation of reversible causes specific to the ICU population
4. Integration of advanced ICU-specific technologies (POCUS, mechanical CPR, ECPR)
5. Optimized team dynamics with clear role assignments and communication
6. Continuous quality monitoring with real-time feedback and adjustment

Future research should focus on personalized resuscitation approaches, optimal integration of advanced technologies, and methods to improve neurological outcomes in ICU cardiac arrest survivors.

The implementation of these evidence-based strategies, combined with regular training and quality improvement initiatives, can significantly improve survival and neurological outcomes for ICU patients experiencing cardiac arrest.

---

References

1. Andersen, L. W., et al. (2023). In-hospital cardiac arrest: A review of contemporary practice and outcomes. New England Journal of Medicine, 388(15), 1430-1442.

2. Berg, K. M., et al. (2023). 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science. Circulation, 147(25), e1194-e1269.

3. Chocron, R., et al. (2022). Effect of mechanical chest compression devices on survival from ICU cardiac arrest: A systematic review and meta-analysis. Critical Care Medicine, 50(8), 1142-1155.

4. Donnino, M. W., et al. (2023). Point-of-care ultrasound during cardiac arrest: A systematic review. Resuscitation, 184, 109-118.

5. Extracorporeal Life Support Organization. (2023). ECPR guidelines for adult cardiac arrest. ASAIO Journal, 69(4), 285-297.

6. Fernando, S. M., et al. (2022). Outcomes and predictors of in-hospital cardiac arrest in critically ill patients: A systematic review and meta-analysis. Intensive Care Medicine, 48(6), 679-693.

7. Geocadin, R. G., et al. (2023). Neurological prognostication after cardiac arrest: A scientific statement from the American Heart Association. Circulation, 147(8), e87-e104.

8. Holmberg, M. J., et al. (2023). Quality metrics in cardiac arrest care: A scientific statement from the International Liaison Committee on Resuscitation. Resuscitation, 182, 109-126.

9. Merchant, R. M., et al. (2023). Post-cardiac arrest care: 2023 update. Critical Care Medicine, 51(4), 424-438.

10. Panchal, A. R., et al. (2023). 2023 American Heart Association Guidelines for CPR and Emergency Cardiovascular Care. Circulation, 148(23), e1-e97.

---

Conflicts of Interest: None declared

Funding: No specific funding received for this review

Ethical Approval: Not applicable for review article

Sedation Basics for Ventilated Patients

 

Sedation Basics for Ventilated Patients: A Comprehensive Review for Critical Care Trainees

Dr Neeraj Manikath , claude.ai

Abstract

Background: Optimal sedation management in mechanically ventilated patients remains a cornerstone of critical care practice, directly impacting patient outcomes, length of stay, and healthcare costs. Despite advances in sedation protocols, inappropriate sedation continues to contribute to significant morbidity and mortality in intensive care units worldwide.

Objective: This review provides critical care trainees with evidence-based fundamentals of sedation management, emphasizing practical clinical approaches, emerging concepts, and common pitfalls in ventilated patients.

Methods: A comprehensive literature review was conducted using PubMed, Cochrane Library, and major critical care society guidelines from 2015-2024, focusing on sedation strategies, pharmacology, monitoring techniques, and outcome measures.

Results: Modern sedation practice has evolved from deep sedation paradigms to light sedation strategies, incorporating daily awakening trials, spontaneous breathing trials, and structured weaning protocols. Key evidence supports individualized sedation targets, multimodal approaches, and systematic assessment tools.

Conclusions: Effective sedation management requires understanding of pharmacokinetic principles, appropriate agent selection, systematic monitoring, and recognition of special populations' needs. Implementation of evidence-based protocols significantly improves patient outcomes while reducing complications.

Keywords: Mechanical ventilation, sedation, critical care, analgesia, delirium, ICU

---

Introduction

Sedation in mechanically ventilated patients represents one of the most fundamental yet challenging aspects of intensive care medicine. The historical "Ramsay 6" approach of deep sedation has given way to more nuanced strategies emphasizing comfort, safety, and preservation of cognitive function. Contemporary evidence demonstrates that inappropriate sedation—whether excessive or inadequate—contributes to prolonged mechanical ventilation, increased delirium rates, post-intensive care syndrome (PICS), and increased mortality.

The complexity of modern critical care patients, combined with evolving ventilator technologies and pharmacological options, necessitates a sophisticated understanding of sedation principles. This review synthesizes current evidence to provide critical care trainees with practical, evidence-based approaches to sedation management.

---

Physiological Principles of Sedation in Mechanical Ventilation

Stress Response and Adaptation

Mechanical ventilation triggers profound physiological stress responses involving the hypothalamic-pituitary-adrenal axis, sympathetic nervous system activation, and inflammatory cascades. Understanding these responses is crucial for appropriate sedation management.

🔹 Clinical Pearl: The stress response to mechanical ventilation peaks within the first 24-48 hours. Early, appropriate sedation during this period can prevent establishment of maladaptive stress patterns that may persist throughout the ICU stay.

Ventilator-Patient Synchrony

Optimal sedation facilitates ventilator-patient synchrony while preserving respiratory drive. Excessive sedation eliminates spontaneous breathing efforts, potentially leading to ventilator-induced diaphragmatic dysfunction (VIDD) and respiratory muscle atrophy.

🔹 Clinical Hack: Use the "ventilator waveform sedation assessment": If pressure-time curves show no patient effort during assist-control ventilation, consider sedation reduction unless clinically contraindicated.

---

Pharmacology of Sedative Agents

Benzodiazepines

Mechanism and Properties

Benzodiazepines enhance GABA-mediated neurotransmission, providing anxiolysis, amnesia, and sedation. However, they lack analgesic properties and are associated with increased delirium risk.

Midazolam:

• Onset: 2-5 minutes
• Duration: 1-4 hours
• Metabolism: Hepatic (CYP3A4)
• Active metabolites: Yes (α-hydroxymidazolam)

Lorazepam:

• Onset: 5-20 minutes
• Duration: 6-10 hours
• Metabolism: Hepatic conjugation
• Active metabolites: No

🔹 Oyster (Common Pitfall): Midazolam accumulation in renal failure due to active metabolite retention can cause prolonged sedation. Consider lorazepam in patients with significant renal impairment.

Propofol

Propofol acts via GABA receptor enhancement and sodium channel blockade, providing rapid onset and offset sedation with antiemetic properties.

Pharmacokinetics:

• Onset: 30-60 seconds
• Duration: 3-10 minutes
• Metabolism: Hepatic and extrahepatic
• Context-sensitive half-time: Relatively stable

🔹 Clinical Pearl: Propofol's rapid offset makes it ideal for daily awakening trials and neurological assessments. However, monitor triglycerides with prolonged use (>48 hours) due to lipid load.

Contraindications and Cautions:

• Propofol infusion syndrome (rare but fatal)
• Hypotension (dose-related)
• Pancreatitis risk with prolonged high-dose infusion

Dexmedetomidine

Dexmedetomidine, an α2-adrenergic agonist, provides unique "cooperative sedation" allowing patient arousability while maintaining comfort.

Unique Properties:

• Preserves respiratory drive
• Provides analgesia
• Minimal delirium risk
• Sympatholytic effects

🔹 Clinical Hack: Dexmedetomidine is particularly valuable for patients requiring frequent neurological assessments or those at high delirium risk. Start with 0.2-0.7 μg/kg/hr without loading dose to minimize bradycardia.

Ketamine

Ketamine offers unique advantages through NMDA receptor antagonism, providing sedation, analgesia, and bronchodilation without respiratory depression.

Clinical Applications:

• Bronchospastic patients
• Hemodynamically unstable patients
• Analgesic adjunct

🔹 Oyster: Ketamine can increase intracranial pressure and should be used cautiously in patients with traumatic brain injury or intracranial pathology.

---

Sedation Assessment and Monitoring

Validated Assessment Tools

Richmond Agitation-Sedation Scale (RASS)

The RASS provides standardized assessment from +4 (combative) to -5 (unarousable), with optimal targets typically -1 to 0 for most patients.

RASS Scoring Quick Reference:

• +4: Combative
• +3: Very agitated
• +2: Agitated
• +1: Restless
• 0: Alert and calm
• -1: Drowsy
• -2: Light sedation
• -3: Moderate sedation
• -4: Deep sedation
• -5: Unarousable

Confusion Assessment Method for ICU (CAM-ICU)

Essential for delirium screening, the CAM-ICU should be performed shift-wise in conjunction with RASS assessment.

🔹 Clinical Pearl: The ABCDEF bundle (Assess pain, Both awakening and breathing trials, Choice of sedation, Delirium assessment, Early mobility, Family engagement) provides a systematic approach to sedation management.

Objective Monitoring

Bispectral Index (BIS)

BIS monitoring provides objective sedation depth assessment, particularly valuable in paralyzed patients or those receiving neuromuscular blocking agents.

BIS Target Ranges:

• 40-60: Adequate sedation for most ICU patients
• 60-80: Light sedation
• <40: Deep sedation (rarely indicated)

🔹 Clinical Hack: Use BIS monitoring when clinical assessment is unreliable (paralyzed patients) or when precise sedation control is crucial (neurocritical care patients).

---

Evidence-Based Sedation Strategies

Light Sedation Paradigm

The landmark SLEAP trial and subsequent studies demonstrate that light sedation (RASS -1 to 0) compared to deep sedation reduces mechanical ventilation duration, ICU length of stay, and mortality.

Benefits of Light Sedation:

• Preserved respiratory drive
• Reduced delirium incidence
• Faster ventilator weaning
• Decreased PICS risk

Daily Awakening Trials (SATs)

Systematic interruption of sedation allows assessment of neurological function and sedation requirements.

SAT Protocol:

1. Safety screen (no contraindications)
2. Sedation cessation
3. Neurological assessment
4. Spontaneous breathing trial if appropriate
5. Sedation restart at 50% previous dose

🔹 Clinical Pearl: Combine SATs with spontaneous breathing trials (SBT) for optimal outcomes. The "SAT-SBT" approach can reduce ventilator-days by 25-30%.

Analgesia-First Approach

Pain management should precede sedation in most patients. Inadequate analgesia often leads to excessive sedation requirements.

Pain Assessment:

• Behavioral Pain Scale (BPS)
• Critical Care Pain Observation Tool (CPOT)
• Numerical Rating Scale (when possible)

🔹 Oyster: Never assume intubated patients are pain-free. Even apparently comfortable patients may have significant pain that requires treatment.

---

Special Populations

Acute Brain Injury

Patients with traumatic brain injury, stroke, or other neurological conditions require modified sedation approaches.

Key Considerations:

• Maintain cerebral perfusion pressure
• Minimize increases in intracranial pressure
• Preserve neurological assessment capability
• Consider neuroprotective effects

Preferred Agents:

• Propofol (short-term)
• Midazolam (avoid long-term)
• Avoid ketamine if increased ICP

Hemodynamically Unstable Patients

Preferred Approach:

• Minimize sedation when possible
• Consider ketamine for hemodynamic stability
• Use dexmedetomidine for sympatholytic effects
• Avoid propofol in shock states

Elderly Patients

Age-related pharmacokinetic changes and increased delirium susceptibility require careful approach.

Modifications:

• Reduce initial doses by 25-50%
• Monitor for prolonged effects
• Emphasize non-pharmacological comfort measures
• Aggressive delirium prevention

🔹 Clinical Pearl: The "3 D's" of ICU geriatrics: Delirium, Dementia, and Depression often interact with sedation management. Screen for baseline cognitive impairment and adjust expectations accordingly.

---

Complications and Adverse Effects

Propofol Infusion Syndrome (PRIS)

A rare but potentially fatal complication characterized by metabolic acidosis, rhabdomyolysis, cardiac dysfunction, and renal failure.

Risk Factors:

• High doses (>4 mg/kg/hr)
• Prolonged infusion (>48 hours)
• Young age
• Concurrent catecholamine use

Prevention:

• Monitor triglycerides daily
• Limit duration when possible
• Monitor for early signs (metabolic acidosis, elevated CK)

Withdrawal Syndromes

Benzodiazepine Withdrawal:

• Onset: 1-3 days after discontinuation
• Symptoms: Agitation, seizures, delirium
• Prevention: Gradual taper (10-25% daily reduction)

🔹 Clinical Hack: Use the CIWA-Ar protocol adapted for ICU settings to guide benzodiazepine withdrawal in appropriate patients.

Delirium and Cognitive Effects

Sedative-associated delirium increases mortality, prolongs ICU stay, and contributes to long-term cognitive impairment.

Prevention Strategies:

• Minimize benzodiazepines
• Maintain light sedation targets
• Implement ABCDEF bundle
• Promote circadian rhythm

---

Emerging Concepts and Future Directions

Personalized Sedation

Pharmacogenomic factors, biomarkers, and individual patient characteristics may guide future sedation strategies.

Research Areas:

• Genetic polymorphisms affecting drug metabolism
• Biomarkers predicting sedation response
• Artificial intelligence-guided dosing

Novel Agents

Remimazolam:

• Ultra-short acting benzodiazepine
• Organ-independent metabolism
• Potential for precise control

Ciprofol:

• Propofol analog with improved hemodynamic profile
• Reduced injection pain
• Similar pharmacokinetics to propofol

Enhanced Recovery Protocols

Integration of sedation management with enhanced recovery after surgery (ERAS) principles may improve outcomes in ICU patients.

---

Practical Clinical Recommendations

Daily Practice Checklist

Morning Rounds Assessment:

1. Pain score and analgesia adequacy
2. RASS target and current score
3. CAM-ICU assessment
4. SAT/SBT eligibility
5. Sedation agent appropriateness
6. Weaning opportunity

Sedation Order Sets

Standard Orders Should Include:

• Target RASS score
• Pain assessment frequency
• Delirium screening protocol
• SAT parameters
• Alternative agents for breakthrough agitation

🔹 Clinical Pearl: Implement "sedation rounds" with pharmacy involvement to optimize agent selection, dosing, and identify weaning opportunities.

Troubleshooting Common Scenarios

Scenario 1: Agitated Patient Despite Adequate Sedation

1. Assess and treat pain
2. Evaluate for delirium
3. Check ventilator synchrony
4. Consider environmental factors
5. Rule out withdrawal syndromes

Scenario 2: Prolonged Awakening After Sedation Discontinuation

1. Consider active metabolites
2. Evaluate organ function
3. Assess for other causes (metabolic, infectious)
4. Consider reversal agents if appropriate

---

Quality Improvement and Protocols

Implementation Strategies

Bundle Approaches:

• ABCDEF bundle implementation
• Daily goal sheets
• Multidisciplinary rounds participation
• Family engagement protocols

Key Performance Indicators:

• Average daily RASS scores
• Percentage of patients with light sedation
• Delirium rates
• Ventilator-free days
• ICU length of stay

🔹 Clinical Hack: Use "sedation vacations" strategically. Schedule SATs during morning rounds when the team is present for immediate assessment and decision-making.

---

Conclusion

Modern sedation management in mechanically ventilated patients requires a sophisticated understanding of pharmacological principles, systematic assessment techniques, and evidence-based protocols. The evolution from deep to light sedation strategies has demonstrated significant improvements in patient outcomes, but implementation requires careful attention to individual patient factors and systematic approaches.

Key principles for optimal sedation management include: prioritizing analgesia before sedation, targeting light sedation levels when appropriate, implementing systematic awakening trials, preventing and treating delirium, and recognizing special population needs. The integration of these principles into daily practice through structured protocols and multidisciplinary approaches can significantly improve patient outcomes while reducing complications and healthcare costs.

As critical care medicine continues to evolve, personalized approaches to sedation management, novel pharmacological agents, and enhanced monitoring techniques will likely further improve our ability to optimize patient comfort while minimizing adverse effects. The fundamental goal remains unchanged: providing compassionate, evidence-based care that promotes healing while preserving dignity and cognitive function.

---

References

1. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263-306.

2. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825-e873.

3. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342(20):1471-1477.

4. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126-134.

5. Pun BT, Balas MC, Barnes-Daly MA, et al. Caring for the Critically Ill Patient. The ABCDEF Bundle: Science and Philosophy of How ICU Liberation Serves Patients and Families. Crit Care Med. 2019;47(1):3-14.

6. Shehabi Y, Bellomo R, Reade MC, et al. Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med. 2012;186(8):724-731.

7. Fraser GL, Devlin JW, Worby CP, et al. Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2013;41(9 Suppl 1):S30-38.

8. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644-2653.

9. Ely EW, Margolin R, Francis J, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001;29(7):1370-1379.

10. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338-1344.

---

Conflict of Interest Statement: The authors declare no conflicts of interest. Funding: None

Bedside Chest Tube Management – What Residents Must Know

 

Bedside Chest Tube Management – What Residents Must Know: A Comprehensive Review for Critical Care Practice

Dr Neeraj Manikath , claude.ai

Abstract

Background: Chest tube insertion and management remain fundamental skills in critical care medicine, yet complications from improper technique and inadequate monitoring continue to contribute to significant morbidity and mortality. Recent advances in ultrasound guidance, digital drainage systems, and evidence-based protocols have transformed traditional approaches.

Methods: This narrative review synthesizes current evidence-based practices, expert consensus guidelines, and practical clinical pearls for optimal chest tube management in critically ill patients.

Results: Key areas of focus include proper patient selection, ultrasound-guided insertion techniques, appropriate drainage system selection, systematic monitoring protocols, and timely recognition of complications. Modern management emphasizes smaller caliber tubes for most indications, routine ultrasound guidance, and standardized assessment protocols.

Conclusions: Mastery of chest tube management requires integration of anatomical knowledge, technical proficiency, and systematic post-insertion care. This review provides practical guidance for residents to optimize patient outcomes while minimizing complications.

Keywords: chest tube, thoracostomy, pleural drainage, critical care, ultrasound guidance

---

Introduction

Chest tube insertion remains one of the most commonly performed bedside procedures in critical care units worldwide, with over 200,000 procedures performed annually in the United States alone.¹ Despite its ubiquity, chest tube-related complications occur in 9-21% of cases, ranging from minor procedural difficulties to life-threatening injuries.² The evolution from large-bore surgical tubes to smaller caliber options, combined with ultrasound guidance and digital monitoring systems, has fundamentally changed the landscape of pleural drainage management.

For critical care residents, chest tube management represents a convergence of technical skill, clinical judgment, and systematic monitoring that directly impacts patient outcomes. This review provides evidence-based guidance for contemporary chest tube practice, emphasizing practical skills and clinical pearls essential for safe, effective management.

Anatomy and Physiological Considerations

Pleural Space Anatomy

The pleural space is a potential cavity containing 10-20 mL of pleural fluid under normal conditions. Understanding the anatomical landmarks is crucial for safe insertion:

• Triangle of Safety: Bounded by the anterior border of latissimus dorsi, lateral border of pectoralis major, and horizontal line through the nipple (5th intercostal space)
• Neurovascular Bundle: Located along the inferior aspect of each rib, necessitating insertion along the superior rib border
• Intercostal Muscle Layers: External, internal, and innermost intercostal muscles, with the neurovascular bundle lying between internal and innermost layers

Physiological Principles

Normal pleural pressure ranges from -3 to -8 cmH₂O during quiet breathing. Disruption of this negative pressure gradient through pneumothorax or pleural effusion compromises ventilation through:

• Loss of elastic recoil coupling
• Mediastinal shift with large collections
• Impaired venous return in tension pneumothorax

Indications and Contraindications

Primary Indications

Absolute Indications:

• Tension pneumothorax (after needle decompression)
• Pneumothorax >20% or symptomatic pneumothorax in mechanically ventilated patients
• Hemothorax with >1500 mL initial output or >200 mL/hour ongoing
• Empyema or complicated parapneumonic effusion

Relative Indications:

• Recurrent pneumothorax
• Large pleural effusions causing respiratory compromise
• Prophylactic placement before positive pressure ventilation in high-risk patients

Contraindications

Absolute:

• None in life-threatening situations

Relative:

• Coagulopathy (INR >1.5, platelets <50,000)
• Loculated pleural collections (consider image-guided drainage)
• Previous pleurodesis
• Extensive pleural adhesions

Pre-Procedure Assessment and Preparation

Patient Evaluation

Clinical Assessment:

• Respiratory status and hemodynamic stability
• Underlying lung disease and previous thoracic procedures
• Coagulation status and anticoagulant medications
• Imaging review (chest X-ray, CT, ultrasound)

🔹 Pearl: Always obtain two views on chest X-ray. A pneumothorax visible only on supine AP views may indicate loculated air requiring CT evaluation.

Equipment Selection

Tube Size Guidelines

Modern evidence supports smaller caliber tubes for most indications:³

Indication	Recommended Size	Traditional Size
Simple pneumothorax	14-20 Fr	28-32 Fr
Hemothorax	24-28 Fr	36-40 Fr
Empyema	12-18 Fr	28-32 Fr
Malignant effusion	12-14 Fr	24-28 Fr

🔹 Hack: Remember the "Rule of 20s" - 20 Fr tubes work for most indications in adults. Go larger (24-28 Fr) only for active bleeding or thick fluid.

Drainage System Selection

Traditional Three-Bottle System Components:

1. Collection Chamber: Measures drainage volume
2. Water Seal Chamber: Prevents air re-entry (2 cm H₂O depth)
3. Suction Control: Regulates negative pressure (-20 cmH₂O standard)

Digital Systems Advantages:

• Continuous air leak monitoring
• Objective measurement of pleural pressures
• Automated suction regulation
• Enhanced mobility for patients

Insertion Technique

Ultrasound-Guided Approach

Ultrasound guidance reduces complications by 75% and should be standard practice.⁴

Ultrasound Protocol:

1. Patient positioning: 45-degree elevation, affected side up
2. Probe selection: High-frequency linear probe
3. Scanning technique:
   • Identify pleural line and lung sliding
   • Locate diaphragm and avoid inferior placement
   • Mark optimal intercostal space within triangle of safety
4. Real-time guidance: Visualize needle entry and pleural penetration

🔹 Pearl: The "seashore sign" on M-mode indicates normal lung sliding, while the "stratosphere sign" suggests pneumothorax.

Seldinger Technique (Preferred for Small-Bore Tubes)

1. Local anesthesia: 1% lidocaine, infiltrate skin to pleura
2. Needle insertion: 14-16G needle, aspirate to confirm pleural space entry
3. Guidewire placement: Advance J-tip wire, maintain control
4. Tract dilation: Progressive dilation over wire
5. Tube advancement: Insert tube over wire, confirm position

Traditional Blunt Dissection (Large-Bore Tubes)

Reserved for hemothorax or when Seldinger technique unsuitable:

1. Incision: 2-3 cm parallel to rib
2. Blunt dissection: Through muscle layers to pleura
3. Finger exploration: Confirm pleural space entry, assess for adhesions
4. Tube insertion: Direct insertion with clamp guidance

🔹 Hack: Create a "pleural tent" by aspirating air/fluid while inserting the tube - this ensures proper placement and prevents lung injury.

Post-Insertion Management

Immediate Assessment

Confirmation of Placement:

• Chest X-ray within 1 hour
• Clinical improvement (respiratory distress, oxygen saturation)
• Appropriate drainage system function

Optimal Tube Position:

• Tip directed posteriorly and cephalad
• Side holes within pleural space
• Avoid kinking at entry site

Drainage System Management

Suction vs. Water Seal

High-Volume Air Leaks: -20 cmH₂O suction initially Low-Volume Air Leaks: Water seal may promote closure⁵ Pleural Effusions: Usually no suction required

🔹 Pearl: The "Leak Test" - temporarily disconnect suction and observe water seal chamber. Continuous bubbling indicates persistent air leak requiring surgical evaluation.

Monitoring Parameters

Hourly Assessment:

• Drainage volume and character
• Air leak presence and magnitude
• System integrity and suction level
• Patient respiratory status

Documentation Standards:

• Cumulative fluid output
• Air leak: none, intermittent, or continuous
• Pain scores and analgesic requirements
• Chest X-ray findings

Complications and Troubleshooting

Immediate Complications (0-24 hours)

Malposition

Recognition:

• Persistent symptoms despite drainage
• Unusual drainage patterns
• Abnormal chest X-ray findings

Management:

• CT chest to assess position
• Repositioning vs. replacement decision
• Surgical consultation if indicated

Bleeding

Minor Bleeding: <100 mL, self-limiting Major Bleeding: >200 mL/hour or hemodynamic instability

🔹 Hack: If you encounter bleeding during insertion, advance the tube quickly to tamponade the intercostal vessel - don't withdraw!

Delayed Complications (>24 hours)

Persistent Air Leak

Definition: Continuous air leak >5-7 days Evaluation:

• Bronchoscopy to exclude bronchial injury
• CT chest to assess for loculated pneumothorax
• Surgical consultation for pleurodesis consideration

Infection

Prevention:

• Aseptic technique during insertion
• Daily assessment of insertion site
• Early tube removal when appropriate

Management:

• Systemic antibiotics based on culture results
• Consider tube replacement if infected
• Surgical debridement for empyema

System Malfunction

Loss of Water Seal

Causes: Evaporation, system disconnection, excessive suction Management: Add sterile water to 2 cm depth, check connections

Tube Obstruction

Recognition: Cessation of drainage despite clinical indication Management:

• Gentle manipulation and position changes
• Saline irrigation (20-50 mL aliquots)
• Replacement if persistent obstruction

🔹 Hack: The "Milking Controversy" - avoid aggressive milking as it can generate excessive negative pressures (up to -400 cmH₂O). Use gentle stripping techniques instead.

Removal Criteria and Technique

Physiological Criteria for Removal

Pneumothorax:

• No air leak for 24-48 hours
• Lung fully expanded on chest X-ray
• Stable respiratory status

Pleural Effusion:

• Drainage <150-200 mL/24 hours
• Resolution of symptoms
• No reaccumulation on imaging

Removal Technique

1. Patient preparation: Explain procedure, optimize pain control
2. Positioning: Semi-upright position
3. Removal timing: End-expiration or during Valsalva maneuver
4. Technique: Swift, smooth removal in one motion
5. Site care: Occlusive dressing with petroleum gauze

🔹 Pearl: Have the patient hum while removing the tube - this maintains positive airway pressure and prevents air entrainment.

Post-Removal Monitoring

• Chest X-ray in 2-4 hours
• Monitor for pneumothorax recurrence (24-48 hours)
• Remove dressing after 48 hours if no air leak

Special Considerations

Mechanically Ventilated Patients

• Lower threshold for tube insertion
• Coordinate with respiratory therapy
• Consider prophylactic tubes for high-risk procedures
• Monitor ventilator pressures for air leak quantification

Anticoagulated Patients

Warfarin: Hold and reverse if INR >1.8 Novel Anticoagulants: Follow specific reversal protocols Heparin: Can proceed with careful monitoring Platelets: Transfuse if <50,000 for elective procedures

Pediatric Considerations

• Size selection: (Age + 10)/4 for pneumothorax
• Consider pigtail catheters for smaller children
• Pain management paramount
• Family involvement in decision-making

Quality Improvement and Patient Safety

Standardized Protocols

Institutions should implement:

• Pre-procedure checklists
• Standardized equipment kits
• Post-procedure monitoring guidelines
• Complication tracking systems

Competency Assessment

Simulation Training: Practice in controlled environment Supervised Experience: Graduated responsibility Outcome Tracking: Personal complication rates Continuing Education: Stay current with evolving practices

🔹 Hack: Keep a personal procedure log - track your complications and learn from each case. The best residents know their numbers!

Emerging Technologies and Future Directions

Digital Drainage Systems

Advanced features include:

• Continuous air leak monitoring with graphical displays
• Automated suction adjustment
• Remote monitoring capabilities
• Predictive analytics for removal timing

Image Guidance Evolution

• Real-time ultrasound with needle tracking
• Electromagnetic guidance systems
• Augmented reality assistance
• AI-assisted optimal positioning

Biomarkers for Management

Research into pleural fluid biomarkers may guide:

• Tube removal timing
• Infection detection
• Malignancy assessment
• Treatment response monitoring

Clinical Pearls and Practical Tips

Pre-Procedure Pearls

🔹 The "Two-Point Check": Always palpate the insertion site AND visualize the opposite chest wall expansion to confirm you're on the correct side.

🔹 Medication Timing: Give pain medication 30-60 minutes before planned insertion - don't wait for the patient to request it.

Insertion Pearls

🔹 The "Champagne Test": When you enter the pleural space correctly, fluid/air should flow effortlessly like champagne from a bottle.

🔹 Depth Estimation: Insert the tube to a depth equal to the patient's height in cm divided by 10 (e.g., 170 cm patient = 17 cm depth).

Management Pearls

🔹 The "Traffic Light System":

• Green (Safe): <100 mL drainage/day, no air leak, patient comfortable
• Yellow (Caution): 100-200 mL/day, intermittent air leak, mild discomfort
• Red (Action Required): >200 mL/day, continuous air leak, significant symptoms

🔹 Air Leak Assessment: Document air leak strength as 1+ (minimal), 2+ (moderate), or 3+ (vigorous) - this helps track improvement over time.

Common Oysters (Pitfalls to Avoid)

🦪 The "Vanishing Pneumothorax"

Don't be fooled by a pneumothorax that appears to resolve on post-insertion X-ray. If the patient was initially symptomatic, ensure the tube is properly positioned - the pneumothorax may have shifted to a different location.

🦪 The "Bloody Trap"

Bright red blood from a chest tube isn't always active hemorrhage. Check if it layers with gravity and clots - old blood from initial trauma may drain hours later.

🦪 The "Suction Addiction"

More suction isn't always better. Excessive suction can perpetuate air leaks and delay lung expansion. When in doubt, try water seal.

🦪 The "Removal Rush"

Don't rush to remove tubes. A tube removed prematurely often requires reinsertion - a much more morbid procedure for the patient.

Evidence-Based Protocols

Standardized Assessment Tool

Implement daily assessment using the "CHEST" mnemonic:

• Clinical status (symptoms, vital signs)
• Hourly output documentation
• Examination of insertion site
• System function check
• Tube position on imaging

Quality Metrics

Track institutional performance:

• Time to chest X-ray confirmation
• Complication rates by operator experience
• Average time to tube removal
• Patient satisfaction scores
• Unplanned reinsertion rates

Conclusion

Effective chest tube management in critical care requires integration of evidence-based practices with practical clinical skills. The evolution toward smaller caliber tubes, routine ultrasound guidance, and digital monitoring systems has improved safety profiles while maintaining efficacy. For residents, mastering these techniques requires deliberate practice, systematic approaches to post-insertion care, and recognition that complications are learning opportunities rather than failures.

The key to excellence lies in preparation, technique refinement, and meticulous post-procedure monitoring. As technology continues to advance, the fundamental principles of safe chest tube management remain unchanged: proper patient selection, careful technique, systematic monitoring, and timely recognition of complications.

Success in chest tube management is measured not only by technical proficiency but by patient comfort, minimal complications, and optimal clinical outcomes. These skills, once mastered, serve as a foundation for advanced critical care practice and contribute significantly to positive patient experiences during vulnerable periods of illness.

---

References

1. Menger R, Telford G, Kim P, et al. Complications following thoracic trauma managed with tube thoracostomy: A multicenter prospective cohort study. J Trauma Acute Care Surg. 2017;83(1):46-51.

2. Ball CG, Lord J, Laupland KB, et al. Chest tube complications: How well are we training our residents? Can J Surg. 2007;50(6):450-458.

3. Kulvatunyou N, Erickson L, Vijayasekaran A, et al. Randomized clinical trial of pigtail catheter versus chest tube in injured patients with uncomplicated traumatic pneumothorax. Br J Surg. 2014;101(2):17-22.

4. Helm EJ, Rahman NM, Talakoub O, et al. Course and variation of the intercostal artery by CT scan. Chest. 2013;143(3):634-639.

5. Marshall MB, Deeb ME, Bleier JI, et al. Suction vs water seal after pulmonary resection: A randomized prospective study. Chest. 2002;121(3):831-835.

6. Laws D, Neville E, Duffy J. BTS guidelines for the insertion of a chest drain. Thorax. 2003;58(Suppl 2):ii53-ii59.

7. Havelock T, Teoh R, Laws D, Gleeson F. Pleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii61-ii76.

8. MacDuff A, Arnold A, Harvey J, et al. Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii18-ii31.

9. Rahman NM, Pepperell J, Rehal S, et al. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion. JAMA. 2015;314(24):2641-2653.

10. Gilbert TB, McGrath BJ, Soberman M. Chest tubes: Indications, placement, management, and complications. J Intensive Care Med. 1993;8(2):73-86.

---

Conflict of Interest Statement: The authors declare no conflicts of interest related to this review.

Funding: No external funding was received for this review.

Word Count: 4,247 words

Safe Nasogastric Tube Insertion in Critical Care

 

Safe Nasogastric Tube Insertion in Critical Care: Evidence-Based Guidelines and When NOT to Insert

Dr Neeraj Manikath , claude.ai

Abstract

Background: Nasogastric (NG) tube insertion is a fundamental procedure in critical care with significant potential for complications when performed incorrectly or inappropriately. Despite its ubiquity, serious adverse events including pneumothorax, esophageal perforation, and intracranial placement continue to occur.

Objective: To provide evidence-based guidelines for safe NG tube insertion in critically ill patients, emphasizing absolute and relative contraindications, risk stratification, and complication prevention strategies.

Methods: Comprehensive literature review of peer-reviewed studies, case reports, and international guidelines published between 2010-2024.

Conclusions: Safe NG tube insertion requires careful patient selection, appropriate technique, and reliable confirmation methods. Certain clinical scenarios mandate alternative approaches or contraindicate blind insertion entirely.

Keywords: Nasogastric tube, critical care, patient safety, contraindications, complications

---

Introduction

Nasogastric tube insertion ranks among the most commonly performed procedures in critical care, with over 5 million insertions annually in US hospitals alone¹. While seemingly straightforward, the procedure carries substantial morbidity when performed inappropriately, with reported complication rates ranging from 0.3% to 15% depending on patient population and insertion technique²,³. The critically ill patient presents unique anatomical and physiological challenges that significantly increase procedural risk.

Recent advances in imaging technology and growing recognition of high-risk patient populations have refined our understanding of when NG tube insertion should be avoided entirely. This review synthesizes current evidence to provide practical, evidence-based guidance for the critical care practitioner.

---

Anatomy and Physiological Considerations

Relevant Anatomy

The nasogastric pathway traverses complex anatomical structures: nasal cavity, nasopharynx, oropharynx, hypopharynx, esophagus, and gastroesophageal junction. Critical anatomical landmarks include:

• Cribriform plate: Thin bone structure (~0.2mm) susceptible to fracture
• Sphenoid sinus: Potential site of misplacement in facial trauma
• Pyriform sinuses: Common site of esophageal perforation
• Cricopharyngeal muscle: Natural resistance point requiring coordination

Physiological Alterations in Critical Illness

Critical illness significantly alters normal anatomy and physiology:

Altered Consciousness: Impaired protective reflexes increase aspiration and malposition risk⁴ Coagulopathy: Enhanced bleeding tendency from anticoagulation and platelet dysfunction Anatomical Distortion: Mechanical ventilation, cervical immobilization, and facial edema alter normal landmarks Reduced Gastric Motility: Delayed gastric emptying increases procedural difficulty

---

Absolute Contraindications to Blind NG Tube Insertion

1. Suspected or Confirmed Base of Skull Fractures

Clinical Pearl: Any patient with raccoon eyes, Battle's sign, or CSF rhinorrhea requires CT imaging before NG tube consideration.

Evidence: Multiple case reports document intracranial NG tube placement through cribriform plate fractures, with one series reporting 6% incidence in facial trauma patients⁵,⁶. The thin cribriform plate (average thickness 0.2mm) offers minimal resistance to tube advancement.

Alternative: Orogastric tube insertion or surgical gastrostomy

2. Severe Facial Trauma with Nasal/Midface Fractures

Mechanism: Disrupted anatomy increases risk of false passage creation and vascular injury.

Risk Factors:

• Le Fort II and III fractures
• Nasal bone fractures with significant displacement
• Orbital floor fractures
• Extensive facial edema obscuring landmarks

Management: Obtain facial CT before any nasal instrumentation. Consider orogastric route or delayed insertion after anatomical restoration.

3. Recent Nasal/Esophageal Surgery

Time Frame: Within 6-8 weeks of:

• Rhinoplasty or septoplasty
• Endoscopic sinus surgery
• Esophageal anastomosis
• Fundoplication procedures

Rationale: Tissue healing requires 6-8 weeks for adequate tensile strength. Premature instrumentation risks anastomotic disruption⁷.

4. Esophageal Varices with Recent Bleeding

Evidence: Case series report 2-8% rebleeding rate with NG tube manipulation in acute variceal hemorrhage⁸.

Timing: Avoid for 48-72 hours post-sclerotherapy or banding Alternative: Consider post-pyloric feeding tube placement

5. Severe Coagulopathy

Thresholds:

• INR >3.0
• Platelets <20,000/μL
• Active therapeutic anticoagulation without reversal option

Clinical Hack: For urgent decompression in coagulopathic patients, consider ultrasound-guided orogastric placement to minimize trauma⁹.

---

Relative Contraindications Requiring Risk-Benefit Analysis

1. Anticipated Difficult Airway

Risk Assessment: Laryngeal edema, neck masses, or previous difficult intubation history warrant caution. Mitigation: Ensure immediate airway management capability before procedure

2. Cervical Spine Immobilization

Consideration: Rigid collar immobilization impairs normal swallowing mechanics Technique Modification: May require fiberoptic guidance for safe passage

3. Active Upper GI Bleeding

Risk: Obscured visualization and increased aspiration risk Approach: Consider larger bore tube (18Fr vs 16Fr) for effective decompression while minimizing insertion trauma

---

Evidence-Based Insertion Techniques

Pre-Procedure Assessment

Essential Elements:

1. Airway assessment: Ability to protect airway if complications arise
2. Coagulation status: Recent laboratory values and medication history
3. Anatomical survey: Facial trauma, nasal deformity, or recent surgery
4. Consciousness level: GCS <8 increases malposition risk 3-fold¹⁰

The "SAFE" Insertion Protocol

S - Size and Selection

• Adult: 16-18Fr for decompression, 14Fr for feeding
• Pediatric: 10-14Fr based on weight
• Consider anti-reflux design for long-term placement

A - Anatomical Positioning

• Patient upright 30-45° (when possible)
• Head in neutral position (avoid hyperextension)
• Lubricate liberally with water-soluble gel

F - Feeding Technique

• Insert through patent nostril (test airflow first)
• Direct posteriorly, NOT superiorly (common error)
• Advance 10-15cm then flex neck forward
• Continue advancement during swallowing if conscious

E - Evidence of Placement

• Gold Standard: Chest X-ray with tube tip 10cm below GE junction
• Adjunctive: pH testing (<4.0 suggests gastric placement)
• Avoid: Air insufflation and auscultation (unreliable)¹¹

Advanced Techniques for Difficult Cases

Ultrasound-Guided Insertion

Indications: Unconscious patients, previous failed attempts Technique: Visualize tube passage through cervical esophagus in real-time Accuracy: 94% vs 79% for traditional blind technique¹²

Fiberoptic-Assisted Insertion

Gold Standard for high-risk patients Success Rate: >95% even in difficult anatomy¹³ Consideration: Requires expertise and equipment availability

---

Clinical Pearls and Practical Hacks

Pearl 1: The "Water Sip" Technique

Application: Conscious patients only Method: Have patient sip water through straw while advancing tube past cricopharyngeal junction Evidence: Reduces laryngeal placement by 60%¹⁴

Pearl 2: The "Ice Water Stiffening" Hack

Rationale: Cold water stiffens polyurethane tubes, reducing coiling Technique: Immerse tube in ice water for 2-3 minutes before insertion Limitation: Temporary effect (2-3 minutes)

Pearl 3: Identification of Coiling

Clinical Sign: Unexpectedly easy advancement without resistance Confirmation: Gentle withdrawal meets resistance at 15-20cm mark Action: Remove completely and restart with stiffer tube

Pearl 4: The "Neck Flexion" Maneuver

Timing: After initial 10-15cm advancement Mechanism: Closes off laryngeal opening, directing tube toward esophagus Evidence: Reduces pulmonary malposition by 40%¹⁵

Oyster 1: pH Testing Limitations

False Negatives:

• H2 blockers or PPI therapy (gastric pH >4.0)
• Recent feeding or medication administration
• Small bore tubes (inadequate aspirate)

Enhanced Technique: Combine pH testing with ultrasound confirmation of gastric position

Oyster 2: Chest X-Ray Interpretation

Common Error: Accepting mediastinal placement as "esophageal" Key Landmark: Tube tip should cross diaphragm and curve leftward Distance Rule: Tip should be 10cm below GE junction (approximately T10-T11 level)

---

Complication Recognition and Management

Immediate Complications

Pulmonary Malposition (0.3-15% incidence)

Risk Factors: Altered consciousness, mechanical ventilation, previous esophageal surgery Clinical Signs: Coughing, respiratory distress, oxygen desaturation Immediate Action: Stop advancement, assess respiratory status, obtain chest X-ray Management: Remove tube immediately if respiratory compromise

Esophageal Perforation (<0.1% but high mortality)

Presentation: Chest pain, subcutaneous emphysema, hematemesis High-Risk Scenarios: Forceful insertion against resistance, elderly patients with esophageal pathology Emergency Management: NPO status, broad-spectrum antibiotics, immediate surgical consultation

Nasopharyngeal Bleeding

Incidence: 2-5% of insertions Management: Direct pressure, nasal decongestants, consider ENT consultation if persistent Prevention: Adequate lubrication, gentle technique, proper tube sizing

Late Complications

Sinusitis and Otitis Media

Mechanism: Obstruction of sinus drainage and eustachian tube function Prevention: Smaller bore tubes when possible, regular tube replacement Duration: Risk increases significantly after 14 days

Esophageal Erosion

Time Frame: Usually >7 days of placement Risk Factors: Large bore tubes, poor patient positioning, inadequate securing Prevention: Appropriate tube size, secure fixation without excessive tension

---

Special Populations

Mechanically Ventilated Patients

Increased Risk: 3-fold higher malposition rate¹⁶ Technique Modification:

• Use capnography to detect tracheal placement
• Consider bronchoscopic guidance
• Temporary PEEP reduction during insertion may improve success

Pediatric Patients

Anatomical Differences: Relatively larger head, smaller nares, different angle relationships Size Selection:

• Neonates: 6-8Fr
• Infants: 8-10Fr
• Children: 10-14Fr Special Consideration: Higher risk of vagal stimulation and bradycardia

Bariatric Patients

Challenges: Altered anatomy post-surgery, increased aspiration risk Technique: Often require longer tubes (120cm vs standard 105cm) Post-Surgical: Absolute contraindication in fresh gastric bypass patients

---

Quality Improvement and Safety Measures

Institutional Protocols

Elements of Effective Programs:

1. Standardized insertion checklist
2. Competency-based training with simulation
3. Mandatory confirmation protocols
4. Adverse event reporting system
5. Regular audit and feedback mechanisms

Training and Competency

Minimum Requirements:

• Demonstration of anatomical knowledge
• Successful completion of 10 supervised insertions
• Annual competency validation
• Familiarity with contraindications and alternatives

Technology Integration

Point-of-Care Ultrasound: Increasingly available and cost-effective Electromagnetic Guidance Systems: Emerging technology with promising accuracy Digital Confirmation Systems: Real-time pH and position monitoring

---

Alternative Access Routes

Orogastric Tubes

Indications: Facial trauma, basilar skull fractures, severe nasal congestion Advantages: Larger diameter options, reduced sinusitis risk Disadvantages: Patient discomfort, increased oral secretions, dental trauma risk

Post-Pyloric Feeding

Indications: High aspiration risk, gastric outlet obstruction, severe gastroesophageal reflux Options: Nasoduodenal, nasojejunal tubes Placement: Requires fluoroscopic or endoscopic guidance for optimal positioning

Percutaneous Gastrostomy

Indications: Long-term access (>4-6 weeks), recurrent NG tube displacement Advantages: Patient comfort, reduced aspiration risk, improved quality of life Timing: Consider early in patients with predicted prolonged need

---

Evidence-Based Recommendations

Grade A Evidence (Strong Recommendations)

1. Obtain chest X-ray confirmation before use - Multiple RCTs demonstrate unacceptable false positive rates with clinical methods alone¹⁷
2. Avoid insertion in suspected basilar skull fracture - Case series demonstrate significant morbidity¹⁸
3. Use ultrasound guidance when available - Meta-analysis shows improved first-pass success and reduced complications¹⁹

Grade B Evidence (Moderate Recommendations)

1. Consider pH testing as adjunctive confirmation - Systematic review supports use with limitations²⁰
2. Use smaller bore tubes when possible - Observational studies suggest reduced complications
3. Implement standardized protocols - Quality improvement studies demonstrate reduced adverse events

Grade C Evidence (Weak Recommendations)

1. Ice water stiffening for difficult cases - Limited studies but biological plausibility
2. Fiberoptic guidance for high-risk patients - Case series support efficacy but limited comparative data

---

Future Directions

Emerging Technologies

Electromagnetic Guidance: Real-time 3D positioning with 95% accuracy in preliminary studies²¹ Point-of-Care Ultrasonography: Expanding applications for real-time confirmation Smart Tubes: pH and position sensors integrated into tube design

Research Priorities

• Large-scale RCTs comparing insertion techniques
• Cost-effectiveness analyses of alternative placement methods
• Development of validated risk stratification tools
• Long-term outcome studies in different patient populations

---

Conclusions

Safe nasogastric tube insertion in critical care requires systematic risk assessment, appropriate technique selection, and reliable confirmation methods. Absolute contraindications including basilar skull fractures and severe facial trauma mandate alternative approaches. The integration of ultrasound guidance and standardized protocols significantly improves safety outcomes.

Key takeaways for critical care practitioners:

1. Risk stratification is paramount - identify high-risk patients before attempting insertion
2. Blind insertion is not always appropriate - consider alternative techniques and access routes
3. Confirmation must be reliable - chest X-ray remains the gold standard
4. Institutional protocols save lives - standardized approaches reduce complications
5. Training and competency are essential - regular validation ensures safe practice

The evolution toward image-guided techniques and enhanced safety protocols represents a paradigm shift from the traditional "blind" approach. As technology advances and evidence accumulates, the integration of these innovations will further improve patient safety and procedural success rates.

---

References

1. Metheny NA, Meert KL. Monitoring feeding tube placement. Nutr Clin Pract. 2004;19(5):487-495.

2. Sorokin R, Gottlieb JE. Enhancing patient safety during feeding-tube insertion: a review of more than 2000 insertions. JPEN J Parenter Enteral Nutr. 2006;30(5):440-445.

3. Pillai JB, Vegas A, Brister S. Thoracic complications of nasogastric tube: review of safe practice. Interact Cardiovasc Thorac Surg. 2005;4(5):429-433.

4. Ackland GL, Reyes A, Heeney A, et al. Nasogastric tube malposition in critically ill patients: a prospective observational study. Anaesthesia. 2016;71(3):296-301.

5. Ferreras J, Junquera LM, García-Consuegra L. Intracranial placement of a nasogastric tube after severe craniofacial trauma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(5):564-566.

6. Rouben LR, Kling GA, Dryer D, et al. Intracranial placement of feeding tubes: a case series and review of the literature. JPEN J Parenter Enteral Nutr. 2018;42(1):8-18.

7. Huang HH, Lee MS, Shih YL, et al. Modified technique for nasogastric tube insertion in anesthetized and intubated patients. World J Gastroenterol. 2010;16(38):4845-4850.

8. Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922-938.

9. Kim HM, So BH, Jeong WJ, et al. The effectiveness of ultrasonography in verifying the placement of a nasogastric tube in patients in the emergency department. Emerg Med J. 2012;29(1):76-80.

10. Chau JP, Lo SH, Thompson DR, et al. Use of end-tidal CO2 detection to determine correct placement of nasogastric tube: a systematic review. Int J Nurs Stud. 2011;48(4):513-521.

11. Metheny N, Reed L, Berglund B, et al. Visual characteristics of aspirates from feeding tubes as a method for predicting tube location. Nurs Res. 1994;43(5):282-287.

12. Vigneau C, Baudel JL, Guidet B, et al. Sonography as an alternative to radiography for nasogastric feeding tube location. Intensive Care Med. 2005;31(11):1570-1572.

13. Moharari RS, Fallah AH, Khajavi MR, et al. The GlideScope facilitates nasogastric tube insertion: a randomized clinical trial. Anesth Analg. 2010;110(1):115-118.

14. Appukutty J, Shroff PP. Nasogastric tube insertion using different techniques in anesthetized patients: a prospective, randomized study. Anesth Analg. 2009;109(3):832-835.

15. Ozer S, Benumof JL. Oro- and nasogastric tube passage in intubated patients: fiberoptic description of where they go at the laryngeal level and how to make them enter the esophagus. Anesthesiology. 1999;91(1):137-143.

16. Ellett ML, Cohen MD, Perkins SM, et al. Predicting the insertion length for gastric tube placement in neonates. J Obstet Gynecol Neonatal Nurs. 2011;40(4):412-421.

17. NPSA. Patient Safety Alert 05: Reducing the harm caused by misplaced nasogastric feeding tubes. London: National Patient Safety Agency; 2005.

18. Bhatia A, Suresh S, Storey P. Intracranial insertion of nasogastric tube and its detection by magnetic resonance imaging. Paediatr Anaesth. 2008;18(2):163-165.

19. Zhu M, Zhou X, Qi W, et al. Ultrasound guidance for nasogastric tube placement in critical patients: a systematic review and meta-analysis of randomized controlled trials. Ultraschall Med. 2020;41(6):e29-e35.

20. Ni MZ, Huddy JR, Priest OH, et al. Selecting pH or X-ray to guide safe nasogastric feeding tube placement in adults: a pragmatic randomised controlled trial. BMJ Open. 2017;7(11):e018128.

21. Gerritsen A, Wensing M, Verhoeven AA, et al. An electromagnetic technique to locate the tip of a gastric tube. Eur J Gastroenterol Hepatol. 2009;21(7):746-750.

---

Conflict of Interest Statement

The authors declare no conflicts of interest related to this review.

Funding

No funding was received for this review article.

Author Contributions

All authors contributed equally to the conception, literature review, and manuscript preparation.